H.R.2869: Increasing Access to Biosimilars Act of 2021

About This Bill

Bill Cosponsors

2 (All Democrats)

Bill Version

Bill Summary

Increasing Access to Biosimilars Act of 2021 This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the...

(Source: Library of Congress)

What Lawmakers Are Saying About This Bill

There is one statement associated with H.R.2869.

Bill Actions

Date Description
April 29, 2021
Referred to the Subcommittee on Health.
April 28, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
April 28, 2021
Referred to the Subcommittee on Health.
April 28, 2021

Introduced in the House by Tony Cárdenas (D-Calif.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page